Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
- None.
- None.
Insights
The collaboration between Augmedix and SADA represents a significant stride in the integration of ambient AI and cloud technology within the healthcare sector. This partnership is poised to enhance the efficiency of medical documentation, which is a critical yet time-consuming task for healthcare providers. By leveraging SADA's expertise in cloud-based technologies and Augmedix's innovative ambient documentation solutions, the alliance is expected to streamline clinical workflows and reduce the administrative burden on clinicians.
From a business perspective, the deployment of these technologies could lead to a reduction in operational costs for health systems due to decreased time spent on documentation. Additionally, the structured data products resultant from this partnership could improve data analytics capabilities, leading to better patient outcomes and more personalized care. This is particularly relevant as the healthcare industry continues to shift towards value-based care models that emphasize efficiency and patient satisfaction.
Augmedix's partnership with SADA, particularly in light of SADA's recent integration with Insight, is indicative of a broader industry trend where healthcare organizations are increasingly adopting cloud and AI technologies. The market for such solutions is growing, as they address the need for real-time, accurate medical documentation and data analysis. By combining forces with a Google Cloud Premier Partner, Augmedix may gain a competitive edge in the market, potentially attracting new clients seeking advanced healthcare technology solutions.
Investors should note the potential for increased market share and revenue growth for Augmedix, driven by the expanded reach and enhanced service offerings. Moreover, the focus on leveraging MedLM models fine-tuned for healthcare use cases could signify a move towards more specialized and sophisticated product offerings, which may resonate well with forward-thinking healthcare systems looking to invest in cutting-edge technology.
The strategic alliance between Augmedix and SADA is a testament to the critical role of interoperability and integration in digital health. The emphasis on seamless point-of-care solutions aligns with the industry's need for technologies that are not only advanced but also user-friendly and easily adoptable by healthcare professionals. The partnership's potential to accelerate the scale of ambient medical documentation and data solutions is likely to have a positive impact on the digital health landscape, fostering innovation and setting new benchmarks for care delivery.
Long-term, the collaboration could catalyze further advancements in ambient AI, prompting other players in the digital health space to follow suit. This may lead to an ecosystem where data-driven insights become integral to clinical decision-making, ultimately elevating the standard of care and patient outcomes while optimizing healthcare resources.
The partnership enables Augmedix to accelerate scaling efforts for digital health solutions and integrations that work seamlessly at the point of care
SAN FRANCISCO, April 04, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced its go-to-market partnership with SADA, an Insight company, a leading cloud business and technology consultancy. The collaboration is focused on leveraging the companies’ combined technology expertise and expanding their reach to provide greater product and service value to health systems seeking high-quality ambient documentation and structured data products.
"We are thrilled to join forces with SADA, to partner with an organization that has a nationwide reach to health systems, and also to leverage their prowess in frontier cloud infrastructure technology, machine learning, integrations, and implementations,” said Ian Shakil, founder, director, and chief strategy officer of Augmedix. “Together, we can accelerate efforts to bring ambient medical documentation and data solutions to benefit more patients and clinicians.”
SADA provides cloud, data, artificial intelligence, cybersecurity, and intelligent edge solutions and services. It is also a service partner for Google Cloud with 10 specializations, including security, infrastructure, cloud migration, data analytics, application development, location-based services, and machine learning. SADA offers unique expertise in frontier Google Cloud Platform (GCP) integrations, focusing on generative AI models, especially MedLM, a family of models fine-tuned for healthcare industry use cases.
"SADA is proud to have provided Augmedix with technical services for many years,” said Michael Ames, managing director of Healthcare and Life Sciences Professional Services. “Now, as part of Insight, we are excited to embark on a new phase of partnership, bringing together our expertise in data and analytics, Insight’s vast reach in the healthcare industry, and Augmedix’s cutting-edge technology to accelerate scalable enterprise adoption for Augmedix. Our combined entities’ reach and capabilities will empower us to advance Augmedix’s products beyond core charting. This partnership represents our commitment to pushing the boundaries of what's possible in healthcare and cloud technology."
As a Google Cloud Premier Partner across several product and engagement models, SADA has deep engineering capabilities across the entire Google Cloud stack and specializes in Google Cloud priority workloads. The go-to-market partnership enables SADA to closely work on reference architecture with Google Cloud and Augmedix, further accelerating Augmedix’s positioning as an innovation partner.
"Augmedix's partnership with SADA will help bring ambient documentation to more healthcare organizations around the country," said Amy Waldron, global director of Healthcare Strategy & Solutions, Google Cloud. "Importantly, this work will help improve how medical data is captured, enhancing efficiency, and ultimately improving patient care. This collaboration underscores our commitment to empowering organizations like Augmedix and SADA to drive meaningful change in the healthcare industry."
About Augmedix
Augmedix (Nasdaq: AUGX) empowers clinicians to connect with patients by liberating them from administrative burden through the power of ambient AI, data, and trust.
The platform transforms natural conversations into organized medical notes, structured data, and point-of-care notifications that enhance efficiency and clinical decision support.
Incorporating data from millions of interactions across all care settings, Augmedix collaborates with hospitals and health systems to improve clinical, operational, and financial outcomes.
Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit www.augmedix.com.
About SADA, an Insight Company
SADA, An Insight company, is a market leader in professional services and an award-winning solutions provider of Google Cloud. Since 2000, SADA has been committed to helping customers in healthcare, media, entertainment, retail, manufacturing, and the public sector solve their most complex challenges so they can focus on achieving their boldest ambitions. With offices in North America, India, and Armenia providing sales and customer support teams, SADA is positioned to meet customers where they are in their digital transformation journey. SADA is a 6x Google Cloud Partner of the Year award winner with 10 Google Cloud Specializations and has been recognized as a Niche Player in the 2023 Gartner® Magic Quadrant™ for Public Cloud IT Transformation Services. SADA has been named to Inc. Magazine’s Best Workplaces four years in a row. Learn more at www.sada.com.
Contact Information
Investors:
Matt Chesler, CFA
FNK IR
646-809-2183
augx@fnkir.com
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
Forward-Looking Statements
This press release contains “forward-looking statements” that involve a number of risks and uncertainties. Words such as “believes,” “may,” “will,” “estimates,” “potential,” “continues,” “anticipates,” “intends,” “expects,” “could,” “would,” “projects,” “plans,” “targets,” “excited,” “optimistic,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking statements include, without limitation, statements regarding the partnership enabling Augmedix to accelerate scaling efforts for digital health solutions and integrations that work seamlessly at the point of care; accelerating our efforts to bring ambient medical documentation and data solutions to benefit more patients and clinicians; furthering Augmedix’s positioning as an innovation partner; Augmedix's partnership with SADA and Google Cloud representing a pivotal moment in healthcare technology; and being poised to revolutionize how medical data is captured, enhancing efficiency and improving patient care. Actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in our most recent Form 10-K filed with the U.S. Securities and Exchange Commission on March 26, 2024, as well as other documents that may be filed by us from time to time with the U.S. Securities and Exchange Commission. The forward-looking statements included in this press release represent our views as of the date of this press release. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.
FAQ
What is the partnership about between Augmedix and SADA?
What are the expertise areas of SADA in the partnership?
How does the partnership benefit healthcare organizations?
What role does Google Cloud play in the partnership?
Who are the key individuals involved in the partnership?
